InvestorsHub Logo
Followers 30
Posts 6551
Boards Moderated 0
Alias Born 08/18/2010

Re: None

Monday, 10/17/2016 10:44:55 AM

Monday, October 17, 2016 10:44:55 AM

Post# of 25790
never happened ...
Paradigm Medical Industries, Inc. (PINKSHEETS: PDMI) announced today that it has been notified by its Italian partner, Costruzione Strumenti Oftalmici (CSO), that all necessary documents have been completed and submitted to the United States Food and Drug Administration (FDA) for the Retimax™, also known as the Paramax. Paradigm is the exclusive representative for this significant new product in the U.S. market. "This new innovative device offers the earliest detection of glaucoma currently available and will be an excellent addition to Paradigm's glaucoma diagnostic products," said Stephen Davis, Paradigm's President and Chief Executive Officer.